Johnson & Johnson sent doctors a warning letter about the increased risk of lymphoma, a blood cancer, in patients taking its rheumatoid arthritis drug Remicade, Reuters reported last week.
The warning comes in the wake of Merck’s decision to pull its arthritis drug Vioxx from all worldwide markets after a study confirmed that it increases a […]

The rheumatoid arthritis drug Remicade from Johnson & Johnson has new warning labels following reports of patients on the drug suffering from blood disorders that in some cases were fatal, the U.S. Food and Drug announced last week.
Johnson & Johnson sent a letter to doctors earlier this month that said, “The causal relationship to Remicade […]